Judge Keeps Pfizer Foe's COVID Vaccine Patent Case Alive

By Andrew Karpan · April 30, 2025, 10:31 PM EDT

The chief judge for the Delaware federal court has turned down a bid from Pfizer and BioNTech to invalidate patent claims asserted against their blockbuster COVID-19 vaccine, in a case set...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

March 17, 2022

Recent Articles By Andrew

April 29, 2025
Fed. Circ. Backs TM Denial Of Dark Green Gloves As Generic
April 25, 2025
Judge Says FDA Can Take Ozempic Off Shortage List
March 28, 2025
Doctor's Counterclaims Cut In 'Groq' TM Feud With Chipmaker
March 21, 2025
Novartis Urges Court To Make FDA Block Entresto Generic
March 18, 2025
ITC To Review Whether Tourniquet Importers Are Ignoring Ban
March 17, 2025
New Bills Target 'Patent Thickets' And 'Product Hopping'
February 24, 2025
Patent Eligibility Appeals 'Will Not Go Away,' Justices Told
February 12, 2025
Labcorp Can't Score New Trial After $384M Patent Loss
February 06, 2025
Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book Row
January 08, 2025
Patent Board Knocks Out Most Of Apple Patent